Capricor Therapeutics Inc
NASDAQ:CAPR 1:37:38 PM EDT
| Market Cap (Intraday) | 515.77M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $15.89 |
| 50-Day MA | $7.12 |
| 200-Day MA | $5.62 |
Capricor Therapeutics Inc Stock, NASDAQ:CAPR
10865 Road to the Cure, Suite 150, San Diego, California 92121
United States of America
Phone: +1.858.727.1755
Number of Employees: 102
Description
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.